Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 10:42pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
Sanofi-Aventis (SNY)
At 5:02AM SGT:
36.29 USD
0.00 (0.00%)
MORE ON SNY
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
SANOFI-AVENTIS SA
(NYSE:SNY) Delayed quote data
Pre-Market:
36.22
0.07 (0.19%)
as of 10:25pm SGT on 02/10/10
Last Trade:
36.29 USD
Trade Time:
5:02AM SGT
Change:
0.00 (0.00%)
Prev Close:
36.29
Open:
N/A
Bid:
N/A
Ask:
N/A
1y Target Est:
42.50
Day's Range:
N/A - N/A
52wk Range:
24.59 - 41.59
Volume:
9,831
Avg Vol
(3m)
:
1,409,300
Market Cap:
94.76B
P/E
(ttm)
:
N/A
EPS
(ttm)
:
N/A
Div & Yield:
1.419 (3.91%)
1d
5d
3m
6m
1y
2y
5y
max
Use Y! Toolbar to track stocks
Add SNY to Portfolio
Download Data
HEADLINES
Flu vaccines boost Sanofi-Aventis
at FT.com
(Wed 9:00pm)
Q4 2009 Sanofi-Aventis Earnings Release - Time Not Supplied
CCBN
(Wed 8:07pm)
Sanofi-aventis Delivers Double-Digit EPS(1) Growth in 2009 as the Transformation Program Progresses
PR Newswire
(Wed 8:00pm)
Germany to Lead Bailout of Greece
at SmartMoney.com
(Wed 7:04pm)
Sanofi-Aventis quarterly net income up 10%
at MarketWatch
(Wed 3:36pm)
Sanofi-aventis Video Q&A : CEO Chris Viehbacher Comments on 2009 Full-Year Earnings
Business Wire
(Wed 2:35pm)
Bone Up On This Potential Blockbuster
at Motley Fool
(Wed 12:58am)
Europe Launches Probe into Pharma Deals
at BusinessWeek
(Tue 11:52pm)
Germany Cancels Swine Flu Vaccines
at BusinessWeek
(Tue 11:52pm)
Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc.
PR Newswire
(Tue 2:36pm)
More Headlines for SNY...
ANALYST
EPS Est (next year)
(Dec-09)
:
7.76
EPS Est (in 2 years)
(Dec-10)
:
7.72
Avg Rec (current)*:
2.3
PEG Ratio:
2.06
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Sanofi-Aventis, a pharmaceutical company, contributes to enhancing life by providing an offering of medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices